⌘K
Loading ticker…
As of 2026-08-24, Aldeyra Therapeutics, Inc. (ALDX) has a 3-month relative strength percentile of 44 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 34. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.8%, relative volume 0.61×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
ALDX is in a stage 4 downtrend, week 6. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -14.1% / -52.1%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
ALDX is held by 13 ETFs as of May 2026. Top owner: VTWO at 0.00% weight, $484K notional. Top 3 carry $885K.
Held by 25 ETFs · $10M across latest filings · largest weight 0.13% (QQQS).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.00% | $484K | — |
| VHTVanguard Health Care ETF | 0.00% | $271K | — |
| GSSC | 0.01% | $130K | −0.03 pp |
| VTWG | 0.00% | $72K | −0.01 pp |
| QQQS | 0.13% | $25K | −0.34 pp |
| VTWV | 0.00% | $14K | — |
| VTHRVanguard Russell 3000 ETF | 0.00% | $8K | — |
| ITWO | 0.00% | $4K | — |
| MSSM | 0.00% | $4K | — |
| URTY | 0.00% | $4K | — |
Showing 10 of 13 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ALDX Jan avg: -4.39% median: -3.68% win: 50% σ: 10.15% n: 4 2022-04-12 → 2026-07-31 | ALDX Feb avg: 7.40% median: 8.22% win: 75% σ: 9.09% n: 4 2022-04-12 → 2026-07-31 | ALDX Mar avg: -4.83% median: 1.43% win: 50% σ: 48.73% n: 4 2022-04-12 → 2026-07-31 | ALDX Apr avg: -16.33% median: -10.06% win: 20% σ: 28.62% n: 5 2022-04-12 → 2026-07-31 | ALDX May avg: -1.11% median: -0.42% win: 40% σ: 12.08% n: 5 2022-04-12 → 2026-07-31 | ALDX Jun avg: 20.63% median: 21.71% win: 60% σ: 37.54% n: 5 2022-04-12 → 2026-07-31 | ALDX Jul avg: 8.93% median: 19.03% win: 60% σ: 24.25% n: 5 2022-04-12 → 2026-07-31 | ALDX Aug avg: 23.68% median: 28.36% win: 75% σ: 24.56% n: 4 2022-04-12 → 2026-07-31 (current) | ALDX Sep avg: -12.89% median: -10.54% win: 0% σ: 7.76% n: 4 2022-04-12 → 2026-07-31 | ALDX Oct avg: -19.36% median: -2.64% win: 25% σ: 36.77% n: 4 2022-04-12 → 2026-07-31 | ALDX Nov avg: 16.45% median: 5.33% win: 75% σ: 30.98% n: 4 2022-04-12 → 2026-07-31 | ALDX Dec avg: 11.84% median: 13.06% win: 75% σ: 16.08% n: 4 2022-04-12 → 2026-07-31 |